BRS Analytical Service, LLC has voluntarily recalled five ophthalmic solutions after an FDA audit detected manufacturing deviations that could compromise product quality. The recall affects over 75,000 cases of artificial tears and eye drops, categorized as Class II by the FDA, signifying potential for reversible health consequences. The notice emphasizes a lack of assurance regarding sterility and unknown health hazards for users. Consumers are advised to check their medicine cabinets and seek further information on the recalled products.
The FDA found 'manufacturing cGMP deviations' in five ophthalmic products, prompting a voluntary recall citing potential unacceptable quality and unknown health hazards.
The recall affects over 75,000 cases, raising concerns about the products' sterility and possible health risks resulting from their use, as classified by the FDA.
Collection
[
|
...
]